Using advanced CRISPR to boost efficiency of CAR-T cell therapies

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the USA and a year later in Europe for treating acute lymphoblastic leukemia (ALL).

Otsuka TV and banner ads for Rexulti draw rebuke from FDA watchdog

Otsuka is the latest pharma in a week to receive a violation letter from FDA’s drug promotion police. Its Rexulti TV commercial and a banner

November 10, 2023

Iron retention in skin linked to psoriasis: Could hepcidin be the missing piece in treatment?

This study reveals hepcidin’s significant role in psoriasis, linking iron retention to inflammation and keratinocyte growth, suggesting new therapeutic targets.

October 1, 2024

Healthy.io Appoints Geoff Martin as CEO to Drive Expansion

Geoff Martin, CEO at Healthy.io What You Should Know: – Healthy.io, the pioneer of smartphone-powered at-home kidney testing, announced Geoff Martin, a seasoned healthcare executive,

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.